Spinal Muscular Atrophy (SMA): One of the most successful applications of RNA therapeutics in rare genetic diseases is the treatment of spinal muscular atrophy (SMA), a neurodegenerative disorder caused by mutations in the SMN1 gene. The gene discussed is SMN1; the disease is proximal spinal muscular atrophy.